{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:16:56Z","timestamp":1787501816305,"version":"build-2736575974"},"reference-count":28,"publisher":"University of Toronto Press Inc. (UTPress)","issue":"1","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Dalhousie Pharmacy Endowment Fund"},{"name":"Drug Evaluation Alliance of Nova Scotia"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Can Pharm J"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Lyme disease is a bacterial infection transmitted to humans through bites from infected\n                      <jats:italic toggle=\"yes\">Ixodes<\/jats:italic>\n                      species of ticks. Prophylaxis with a single dose of oral doxycycline following a bite from an infected tick reduces the risk of developing Lyme disease. Pharmacists in Nova Scotia (NS) were among the first in Canada to prescribe for this indication. The primary objective of this study is to describe experiences with pharmacist prescribing of prophylaxis after tick bites in NS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective cohort study was performed using health administrative data 16\u2009months before and after pharmacists were authorized to prescribe Lyme disease chemoprophylaxis (August 1, 2021). All dispensations of a single dose of oral doxycycline from a community pharmacy in NS were included. Data collected included prescriber type, date, and county of dispensation. Comparisons of dispensations were completed before and after pharmacists gained prescriptive authority and relative to other prescribers. Dispensations were described descriptively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Over the study period, 12,549 single-dose doxycycline prescriptions were dispensed in NS: 3900 prescriptions were dispensed before pharmacist prescribing authorization for this indication occurred and 8649 were dispensed after. Pharmacists prescribed 61.3% of all single-dose doxycycline prescriptions following implementation of prescribing authority.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>An increase in single-dose doxycycline prescriptions was observed in NS. Pharmacists have become the primary prescribers for Lyme disease chemoprophylaxis in the province.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Patients were willing to be assessed for chemoprophylaxis after tick exposure by pharmacists, and pharmacist prescribing for this indication suggests increased access to post-tick exposure care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17151635241290519","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T01:16:10Z","timestamp":1731719770000},"page":"47-54","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Lyme disease chemoprophylaxis prescribing before and after pharmacist prescriptive authority in Nova Scotia"],"prefix":"10.3138","volume":"158","author":[{"given":"Madison","family":"Bell","sequence":"first","affiliation":[{"name":"College of Pharmacy, Dalhousie University, Halifax, NS"},{"name":"Nova Scotia Health, Halifax, NS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasha","family":"Ramsey","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Dalhousie University, Halifax, NS"},{"name":"Nova Scotia Health, Halifax, NS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7982-4437","authenticated-orcid":false,"given":"Shanna","family":"Trenaman","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Dalhousie University, Halifax, NS"},{"name":"Geriatric Medicine Research, Nova Scotia Health, Halifax, NS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Hatchette","sequence":"additional","affiliation":[{"name":"Department of Pathology, Dalhousie University, Halifax, NS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Campbell","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Dalhousie University, Halifax, NS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bishop","sequence":"additional","affiliation":[{"name":"Nova Scotia College of Pharmacists, Halifax, NS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"MacInnis","sequence":"additional","affiliation":[{"name":"Pharmacy Department and Emergency Department, IWK Health, Halifax, NS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Hurley","sequence":"additional","affiliation":[{"name":"Division of Pediatric Emergency Medicine, Dalhousie University, Halifax, NS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8230-9807","authenticated-orcid":false,"given":"Emily","family":"Black","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Dalhousie University, Halifax, NS"},{"name":"Nova Scotia Health, Halifax, NS"},{"name":"IWK Health, Halifax, NS"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1696","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1215"},{"key":"e_1_3_2_3_2","unstructured":"Lyme disease. IPAC Canada. Available: https:\/\/ipac-canada.org\/lyme-disease (accessed Jun. 30 2023)."},{"key":"e_1_3_2_4_2","unstructured":"Communicable disease prevention and control: Lyme disease. Government of Nova Scotia. 2021. Available: https:\/\/novascotia.ca\/dhw\/cdpc\/lyme.asp (accessed Nov. 4 2023)."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2110.141640"},{"key":"e_1_3_2_6_2","unstructured":"Lyme disease: prevention and treatment. Public Health Agency of Canada. 2022. Available: https:\/\/www.canada.ca\/en\/public-health\/services\/diseases\/lyme-disease.html (accessed Jun. 3 2023)."},{"key":"e_1_3_2_7_2","unstructured":"Lyme disease epidemiology and surveillance in Nova Scotia. Nova Scotia Department of Health and Wellness. 2012. Available: https:\/\/novascotia.ca\/dhw\/populationhealth\/documents\/Lyme-Disease-Epidemiology-and-Surveillance-in-Nova-Scotia.pdf (accessed Jun. 3 2023)."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq097"},{"key":"e_1_3_2_9_2","unstructured":"Nova Scotia Infectious Diseases Expert Group. Guidance for primary care and emergency medicine providers in the management of Lyme disease human granulocytic anaplasmosis babesiosis and Powassan virus infection in Nova Scotia. Nova Scotia Department of Health and Wellness. 2023. Available: https:\/\/novascotia.ca\/dhw\/cdpc\/documents\/statement_for_managing_ld.pdf (accessed Jun. 3 2023)."},{"key":"e_1_3_2_10_2","unstructured":"Nova Scotia action for health\u2014public reporting. Nova Scotia Health. 2022. Available: https:\/\/public.tableau.com\/app\/profile\/nova.scotia.health\/viz\/ActionforHealth-PublicReporting\/Overview (accessed Jun. 30 2023)."},{"key":"e_1_3_2_11_2","unstructured":"Standards of practice: prescribing drugs. Nova Scotia College of Pharmacists. 2023. Available: https:\/\/www.nspharmacists.ca\/wp-content\/uploads\/2016\/05\/SOP_PrescribingDrugs_Dec2022.pdf (accessed Jun. 3 2023)."},{"key":"e_1_3_2_12_2","unstructured":"Frequently asked questions. Alberta College of Pharmacy. Available: https:\/\/abpharmacy.ca\/faq\/faq?shs_term_node_tid_depth=185 (accessed Jun. 3 2023)."},{"key":"e_1_3_2_13_2","unstructured":"Minor ailments. Ontario College of Pharmacists. 2023. Available: https:\/\/www.ocpinfo.com\/practice-education\/expanded-scope-of-practice\/minor-ailment\/ (accessed Jun. 3 2023)."},{"key":"e_1_3_2_14_2","unstructured":"Assessment and prescribing for Lyme disease prophylaxis by pharmacists. Government of New Brunswick. 2023. Available: https:\/\/www2.gnb.ca\/content\/gnb\/en\/departments\/health\/MedicarePrescriptionDrugPlan\/content\/drugplans\/InformationForHealthCareProfessionals\/pharmacy_services\/lyme_disease.html (accessed Jun. 3 2023)."},{"key":"e_1_3_2_15_2","unstructured":"Lyme disease. Centers for Disease Control and Prevention. 2022. Available: https:\/\/www.cdc.gov\/lyme\/index.html (accessed Jun. 3 2023)."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2211934"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz866"},{"key":"e_1_3_2_18_2","unstructured":"Health data Nova Scotia. Dalhousie University. Available: https:\/\/medicine.dal.ca\/departments\/department-sites\/community-health\/research\/hdns\/about.html (accessed Jun. 26 2023)."},{"key":"e_1_3_2_19_2","unstructured":"Drug information system. Government of Nova Scotia. Available: https:\/\/novascotia.ca\/dhw\/ehealth\/dis\/ (accessed Jun. 26 2023)."},{"key":"e_1_3_2_20_2","unstructured":"Nova Scotia population census estimates by county and census subdivision\u2014July 1 2022. Province of Nova Scotia. 2022. Available: https:\/\/novascotia.ca\/finance\/statistics\/archive_news.asp?id=18492&dg=&df=&dto=0&dti=3#:~:text=Between%20July%201%2C%202021%20and as%20of%20July%201%2C%202022 (accessed Dec. 3 2023)."},{"key":"e_1_3_2_21_2","unstructured":"Nova Scotia population census estimates by county and census subdivision\u2014July 1 2021. Province of Nova Scotia. 2021. Available: https:\/\/novascotia.ca\/finance\/statistics\/archive_news.asp?id=17453 (accessed Dec. 3 2023)."},{"key":"e_1_3_2_22_2","unstructured":"Lyme disease: surveillance. Government of Canada. 2023. Available: https:\/\/www.canada.ca\/en\/public-health\/services\/diseases\/lyme-disease\/surveillance-lyme-disease.html#a2 (accessed Jul. 24 2023)."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.1307799"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263243"},{"key":"e_1_3_2_25_2","volume-title":"The impacts of climate and land use change on tick-related risks","author":"Elmieh N.","year":"2022","unstructured":"Elmieh N. The impacts of climate and land use change on tick-related risks. Vancouver (BC): National Collaborating Centre for Environmental Health; 2022."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v45i04a02"},{"key":"e_1_3_2_27_2","unstructured":"Public data. eTick. 2021. Available: https:\/\/www.etick.ca\/etickapp\/en\/ticks\/public\/map (accessed Jul. 24 2023)."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2020.01.002"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2014.13106"}],"container-title":["Canadian Pharmacists Journal \/ Revue des Pharmaciens du Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17151635241290519","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17151635241290519","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17151635241290519","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T22:05:01Z","timestamp":1772834701000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17151635241290519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1177\/17151635241290519"],"URL":"https:\/\/doi.org\/10.1177\/17151635241290519","relation":{},"ISSN":["1715-1635","1913-701X"],"issn-type":[{"value":"1715-1635","type":"print"},{"value":"1913-701X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,15]]}}}